Robert Wiesenthal
Analyst · Oppenheimer. Your line is open
Thank you, Ravi. Good afternoon, everyone. I'd like to thank you for your interest in Blade and welcome you to our earnings call for the third quarter ended September 30, 2022. Our financial performance in the third quarter was once again well ahead of our expectations. Revenue in the September quarter increased 125% to $45.7 million versus $20.3 million in the comparable 2021 period, contributing to another record quarter for both revenue and flight profit and establishing year-to-date revenue of $108 million for just the first 9 months of the year. Importantly, on a pro forma basis, assuming the acquisitions of Trinity Air Medical, Blade Canada and Blade Europe closed for the comparable period last year, our organic revenue growth would have been approximately 60%. This figure demonstrates that our strategy of aggregating the world's best use cases for urban and mobility solely focused on businesses and new regions that are profitable, with existing aircraft technology continues to serve our company and our shareholders well. To that end, we closed our three European acquisitions on September 1, 2022, giving us a leading position in the largest helicopter market on the continent. Adding this formidable presence in Europe to our existing operations in the U.S., Canada and India is a very important step in our expansion and it cements our position as the largest operating urban and mobility company across three continents. We look forward to deploying our brand, technology and the renowned customer service across these geographies to further accelerate our growth and fortify our global presence. In addition to geographic expansion, we have also continued to diversify Blade's business across end markets with nearly half of our $133 million in trailing 12-month revenue now coming from Organ Transportation or what we call like MediMobility. This division delivered another record quarter of revenues. And for those who are new to the Blade story, I want to take a moment to shed light on this very important business. Air Organ Transport is a large and growing market that is uncorrelated with the economic environment is entirely B2B with multiyear contracts as minimal marketing expenses and most importantly, provides critical life-saving logistics to transplant recipients. Before Blade entered the market, many hospitals called on smaller mom-and-pop operators who often did not have the right aircraft for a given mission and did not have a 24/7 logistics team and robust technology as plagued us. This added time, cost and logistical risks, in some cases, forced transplant centers to forego opportunities to recover organs needed by their patients. Blade entered the organ transportation market because we saw an opportunity to leverage the combined buying power of our entire customer base across our vast network of highly vetted aircraft operators, as well as our logistics and technology platform built over seven years for our passenger business, providing hospitals with better speed, pricing and reliability in a way that few others can match. We doubled down this business last year with our acquisition of Trinity in September 2021 and the proof is * apparent in our results. Today, not only are we the largest dedicated air transporter of human organs for transplant in the United States, but we believe we are the most flexible, reliable and low-cost provider. This cost advantage, combined with our expertise in logistics, customer service and trusted brand gives us confidence in our ability to continue to grow our market share from the high teens level today to eventually becoming the majority of the market. MediMobility is also a great fit for our transition strategy to next-generation aircraft as all trips include a last mile component currently operated by helicopter or ambulance. Given the urgency of the mission, we believe these last mile trips, particularly those where the organized and accompanied will be the very first Blade * mission to transition to electric flight either using Electric Vertical Aircraft, what we call EVA, or drones. However, the industry is not waiting and neither are we as we continue to successfully grow our business using conventional aircraft every day. We ended the third quarter with a total of 67 hospital and organ procurement organization clients, up from less than 30 at the start of the year, and we look forward to rolling out our excellent service to even more customers in the months ahead. In short distance this quarter, we delivered exceptional performance benefiting from higher seat pricing and utilization, which was further boosted by our acquisitions in Canada and Europe. Blade Airport which connects travelers between Manhattan and New York area airports continues to make progress towards profitability, and we remain encouraged by the sequential growth in volume and pricing that we are now experiencing. October was our highest revenue month ever for airport and last week, we set a new weekly revenue record as well as a record number of flying passengers. All of this has led to significant growth in flight profit which was up 108% versus the prior year period. At the same time, we're driving efficiency from our operating expenses. Total corporate expenses continue to decrease as a percentage of revenue, down to 43% this quarter versus 70% in the prior year period. On an adjusted basis, excluding noncash and nonrecurring items, corporate expense declined to 30% of revenue, demonstrating the strong leverage of our operations platform and our clear path to profitability. In addition to our financial success, we're making great progress on other strategic initiatives. We continue to build on our fantastic partnership with JetBlue. Those of you who have flown JetBlue 2 or from New York City will have already noticed the initial rollout of our joint marketing program, including the ability to book your Blade Airport transfer in flight by scanning the QR codes displayed on all JetBlue seatback screens or by using your TrueBlue frequent flyer points for blade benefits provided by JetBlue. We look forward to a continued expansion of this important partnership with additional blade benefits for JetBlue flyers coming soon. We have also expanded our partnership with Eve Air Mobility Embraer's Electric Vertical Aircraft company conducting Urban Air Mobility simulations in both Chicago and India. As part of the EVE Chicago Experience in September, Blade enabled fliers to seamlessly commute between downtown Chicago and the suburbs of Illinois. In India, our joint venture partners have entered into a non-binding agreement to acquire up to 200 Eve aircraft, once they are certified for passenger flight in India. In the meantime, they are preparing to launch a three-month co-branded Urban Air Mobility simulation using helicopters between Bangalore Airport and the Bangalore city center this month, turning an hour-long drive into just a minutes-long flight. These demonstrations, funded solely by Eve, show the potential for urban air mobility to significantly reduce commute times in new locations around the world and demonstrates Blade's importance to OEMs in developing the ecosystem for urban air mobility. We're excited to continue supporting our partners as they get closer to commercialization. In the U.S., planning continues for our Electric Vertical Aircraft demonstration flight in the greater New York City area with our partner, Beta Technologies. While we are currently targeting mid-December, this date could slide into the new year as we ensure the test aligns with Beta's ongoing flight test program with the U.S. Air Force. We look forward to sharing more details about the timing and location of this test flight in the coming weeks. Lastly, our President, Melissa Tomkiel, was appointed by Secretary of Transportation Pete Buttigieg to the FAA Advanced Aviation Advisory Committee. Melissa will provide an important and practical perspective for the FAA as they formulate future air mobility policy. In summary, I could not be happier with how well we are positioned for air mobility, both today and in the future. And with that, I'll turn the call over to Will.